Rizobacter Argentina S.A.’s $16 Million Notes Private Placement


Perez Alati, Grondona, Benites & Arntsen and DLA Piper advised on the deal

Rizobacter Argentina S.A. executed ist private placement of $16 Million Notes. Inversiones Odisea subscribed $13 Million Notes and the investment fund Compass Latam High Yield Fondo de Inversión – managed by Compass Group Chile S.A. Administradora general de Fondos – subscribed a total ammount of $3 Million notes.

Rizobacter Argentina S.A. engages in the research, development, and sale of microbiological products applied to agricultural activities in Argentina and internationally. The company, led by Ricardo L. Yapur, operates as a subsidiary of Bioceres S.A..

Perez Alati, Grondona, Benites & Arntsen advised Inversiones Odisea with a team including Jorge L. Pérez Alati (Picture), Guillermo E. Quiñoa, María Gabriela Grigioni, Guido Meirovich, Valeria Stemkauskas, Cristian Marcos Chang and Facundo Fernández Santos.

DLA Piper Argentina advised Compass Group Chile S.A. with Alejandro Noblia.

Involved fees earner: Alejandro Noblia – DLA Piper; Cristian Marcos Chang – Pérez Alati, Grondona, Benites & Arntsen; Facundo Fernández Santos – Pérez Alati, Grondona, Benites & Arntsen; María Gabriela Grigioni – Pérez Alati, Grondona, Benites & Arntsen; Guido Meirovich – Pérez Alati, Grondona, Benites & Arntsen; Jorge Perez Alati – Pérez Alati, Grondona, Benites & Arntsen; Guillermo Quiñoa – Pérez Alati, Grondona, Benites & Arntsen; Valeria Stemkauskas – Pérez Alati, Grondona, Benites & Arntsen;

Law Firms: DLA Piper; Pérez Alati, Grondona, Benites & Arntsen;

Clients: Compass Group Chile S.A.; Inversiones Odisea;

Avatar

Author: Ambrogio Visconti.